GENERAL INFORMATION CONTENT TYPE

Transcription

1 GENERAL INFORMATION Full name: European Journal of Ophthalmology Journal name abbreviation: Eur J Ophthalmol ISSN E-ISSN ISSN Editor in Chief: Prof. Rosario Brancato Co-Editor: Francesco M. Bandello Indexed in: CURRENT CONTENTS(c)/Clinical Medicine Science Citation Index (c)expanded ISI Alerting Services Index Medicus(c)/MEDLINE(c) EMBASE/Excerpta Medica Ocular Resources Computer-Scan Pascal Data Base of INIST The European Journal of Ophthalmology was founded in 1991 and is issued in print bi-monthly. It publishes only peer-reviewed original research reporting clinical observations and laboratory investigations with clinical relevance focusing on new diagnostic and surgical techniques, instrument and therapy updates, results of clinical trials and research findings. CONTENT TYPE Original articles. Previously unpublished manuscripts, directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, relevant clinical laboratory investigations. An original article should consist of around doublespaced, typewritten pages, corresponding to 6-8 printed pages. The text of articles must be divided into sections with the headings Introduction, Methods, Results and Discussion Case reports: The European Journal of Ophthalmology receives more case reports than can be included in the print journal. Case reports will only be considered IF THEY ADD RELEVANT NEW INFORMATION, not simply new cases of an established condition. Case reports must be limited to 6 (six) double-spaced, typewritten pages, with no more than 7 (seven) references and no more than 3 (three) figures. A figure with more parts (for example Fig. 1a, Fig. 1b, Fig. 1c) will be considered as 3 figures. Case reports must conform to the Guidelines for the Manuscript file below. Surgical techniques: Previously unpublished short manuscripts describing innovative surgical tecniques. The recommended length of a surgical technique report is around 6 (six) doublespaced, typewritten pages. It should include no more than 4 figures and 7 references. A figure with more parts (for example Fig. 1a, Fig. 1b, Fig. 1c) will be considered as 3 figures. The text of surgical technique reports must be divided into sections with the headings Introduction, Methods, Results and Discussion. Letters to the Editor: Letters to the Editor are intended to present comments on articles published by the Journal within the last 8 weeks. Refer to the Guidelines for Letters to the Editor below. Editorials and Reviews are solicited by the Editor-in Chief.

2 ETHICAL CONSIDERATIONS To protect its integrity and to ensure the most reliable information to its readers, the European Journal of Ophthalmology will not consider manuscripts that have appeared, in part or in total, in other publications. Likewise, updates of previously published studies that add little data to an existing publication will not be considered. Manuscripts submitted to the European Journal of Ophthalmology must be an original contribution not previously published in any language or country (except as an abstract or preliminary report) and must not be under consideration for publication elsewhere. The Editors are responsible for establishing and maintaining the highest possible standards of the Journal as well as for maintaining its integrity and consider research and publication misconduct to be a serious breach of ethics. Authors who violate ethical considerations such as duplication and plagiarism, will face disciplinary actions. Plagiarism is when an Author reproduces another work without appropriate citation and credit. Plagiarism, whether intentional or not, is a serious violation of ethics. Duplicate submission/publication occurs when two or more papers without full cross-reference, share the same hypothesis, data, discussion and conclusion. The Journal will apply sanctions to individual authors depending on their type of involvement with the article. In serious cases the manuscript will be retracted and the Journal will refuse to accept submission from the same authors. The Editor-in-Chief and the Editorial Board are primarily responsible for ensuring a fair review process and will give unbiased consideration to all submitted manuscripts. The final responsibility rests with the authors, not with the Journal, its Editors, or the Publisher and the statements and opinions contained in the articles published in the European Journal of Ophthalmology are solely those of the individual Authors and contributors. Authors who distribute e-print, preprints, reprints or content in any format including digital copies of an article before print publication may have their accepted manuscript rejected. If accepted, manuscripts must not be published elsewhere in similar form, in any language or country. Publication of the material elsewhere (duplicate publication) without permission of the Journal is a copyright infringement. AUTHORSHIP Authorship criteria Each person listed as an author is expected to have participated in the study to a significant extent. To qualify for authorship, authors must have participated sufficiently in the work to take public responsibility for the content. The participation must include conception and design of the Manuscript, data acquisition or data analysis and interpretation, drafting of the manuscript and/or revising it for critically important intellectual content, revision of the manuscript and statistical analysis, obtaining funding, administrative, technical or material support, or supervision. Corresponding Author The Corresponding Author is the person responsible for a submission and all communication with the Journal regarding that submission. It is the Corresponding Author s responsibility to be sure that all Authors meet the required authorship criteria indicated above. The Corresponding author is expected to update regularly his/her personal information ( , telephone numbers, address) during the entire evaluation and publication process, as any enquiry on a manuscript is answered only to the Corresponding author. Guest/Ghost Authors Based on the definition of guest authorship as the designation and acknowledgment of an individual who does not meet authorship criteria and ghost authorship as the failure to designate an individual who has made a substantial contribution to the research or writing of a ma-

3 nuscript (see the paper in JAMA. 2008; 299 (15): ), THE JOURNAL DOES NOT ALLOW GHOST AUTHORSHIP. If it comes to light that substantial contribution has not been disclosed, the Editor shall advise the corresponding author and withdraw the submission from the system. The assistance of any guest authors, that is a person who has prepared a manuscript draft for the named authors to edit or if the named authors prepared the manuscript and received writing and formatting assistance can be acknowledged at the end of the manuscript, just above the references. If not self employed, the guest author should disclose the name of their employer and the funding source. Change in authorship Once a manuscript has been submitted, the order of Authorship (including adding or removing Authors) CAN NOT be changed without a written request to the Editorial Office (ejo@brancato. net ) from the Corresponding Author. A statement must be included in the request reporting that all authors are in agreement with the change. A new copyright transfer form, signed by all authors must be submitted. Both request and copyright transfer form must be signed by all authors. If an author is removed, a letter from that author agreeing to his/her removal is required. If there is any open questions regarding authorship please withdraw the paper. AUTHORSHIP CHANGES CAN NOT BE SUBMITTED WITH PROOF CHANGES. The publisher is not allowed to make such changes and it will delay the publication of your manuscript. COPYRIGHT Transfer of Copyright All manuscripts submitted for publication must be accompanied by the Copyright Transferand Authorship responsibility form. This form states that each author owns the copyright or has written permission to use all the material in the article. This form must be downloaded from the journal s website, completed in print, signed by all authors, scanned and uploaded with the manuscript upon submission. More forms can be used if necessary. If uploading is not possible, please FAX the form to as soon as possible. Your manuscript WILL NOT be processed until the Copyright Transfer Form, signed by all authors, is received. Use of copyrighted material If the manuscript submitted includes parts to which the authors do not own copyright, then a a written authorization from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the original source. Give yourself ample time to request and receive permission. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material not of Wichtig Editore or of EJO. Patient anonymity and informed consent It is the Authors responsibility: - to protect patients anonymity. When a patient is identifiable in a photograph, the Author(s) must supply the Journal with evidence of the patient s permission to publish the photograph. If necessary, Author(s) should mask the figure accordingly and remove names. - if manuscripts report the results of experimental investigation on human subjects, human derived materials, or human medical records, include a statement that the study was performed with informed consent and following all the guidelines for experimental investigation in human subjects required by the Institutional Review Board (IRB)/Ethics Committee of which all authors are affiliated. Financial disclosures Authors are required to disclose any sponsorship or funding arrangements relating to their research and any possible conflicts of interest. Financial interest is defined as any financial gain or expectancy of financial gain brought to the Author or to his/her family; ownership of stock options in a manufacturing company; involvement in any for-profit or not-for-profit corporation

4 where the Author or his/her family is a director or recipient of a grant, including consultant and travel aid. Conflict of interest statements will be published in the article. Compliance with public funding A number of research funding agencies now require authors to submit the article after publication to a repository that is accessible online by all without charge. Authors of such works should clearly indicated in the financial disclosures such funding. Post-publicatin means the article after peer reiview and acceptance but not the finished, copy-edited and proofed article. ONLINE MANUSCRIPT SUBMISSION Manuscripts must be submitted online at Refer to the Author Tutorial supplied online which offers detailed instruction or initial and revised submission. If you have submitted a manuscript or acted as a reviewer for the European Journal of Ophthalmology since 2007 a username and password have been provided. The username and password are the same for any role you have in the system. If you cannot retrieve it or if you think you have registered before, please contact the Editorial Office ([email protected]) before you register again. First-time users: Please click the Register button from the menu and enter the requested information. On successful registration, you will be sent an indicating your username and password. Print a copy of this information for future reference. If you wish to change any of the data in your profile, log in with your current username and password and update your profile. You only need to register once and should always use the same address. Authors: Please click the log-in button from the menu at the top of the page and log into the system as an Author. Submit your manuscript according to the author instructions. Once you have initiated a submission you can leave it and continue later, as the system will save your information. The Corresponding Author will be able to track the progress of the submission through the system. Should you have any difficulties, please contact the Editorial Office (ejo@ brancato.net). Manuscripts that do not adhere to the following guidelines will be returned to the Corresponding Author for technical revision before undergoing the peer review process. Upon submission you will be required to submit separate files for: - Manuscript file, consisting of title page, manuscript text, acknowledgements, references, figure legends, tables - Summary statement; - Figures - Copyright Transfer Statement We strongly recommend that each time authors log in to the system they check the address registered for correspondence. GUIDELINES FOR THE MANUSCRIPT FILE All manuscript pages must be numbered. TITLE PAGE The title page must include: a) the complete manuscript title (max 135 characters including letters and spaces); b) short title (max 75 characters including letters and spaces);

5 c) all authors listed as first name, initials and last name (i.e. Paul M. Smith) with highest academic or medical degree and departmental affiliation (identified by arabic numerals) d) corresponding Author s information (full mailing address, phone and fax numbers, address); e) Disclosures on - Conflict of Interest (state any financial interest held by the authors or their families; if there is no conflict of interest add a statement None of the authors has conflict of interest with the submission ); - Financial support in form of Grants and funds received in support of the Study. If no financial support was received, add a statement No financial support was received for this submission ; - Meeting presentation. If the paper was presented at a meeting, state its name, place and date on which it was read; - Informed consent. In case of manuscripts reporting the results of experimental investigation on human subjects, human derived material or human medical records include a statement that the study was performed with informed consent and following all the guidelines for experimental investigations required by the Institutional Review Board or Ethics Committee of which all authors are affiliated. f) Structured abstract, which must not exceed 250 words and which must be structured and divided in the sections Purpose, Methods, Results, and Conclusions. It must be acceptable for use without revision. g) Below the abstract, identify 3 to 6 keywords in alphabetical order under which you believe the article should be indexed. h) If you are submitting a manuscripts which has been previously rejected please inform the Journal and the Reviewers of the previous review comments, how and where the manuscript has been improved according to the reviewers comments. MANUSCRIPT TEXT Starting on a new page, type manuscript using Arial font size 12, as this creates less problems when building your PDF, and save it as Word document (.doc). Use double spacing and do not justify the right margin. Use only standard abbreviations and avoid abbreviations in the title. The full term for which an abbreviation stands for should preceed its first use in the text. The average published manuscript in European Journal of Ophthalmology, including references, is up to 6 pages in length. This corresponds to between 16 and 20 double-spaced typewritten pages. Type your manuscript as a single Word file, divided in the following sections: Introduction: should be pertinent to the study but not an in-depth review of the literature. Materials and methods: should be clearly defined so that the study may be duplicated by other investigators. Results: should be as concise as possible. Discussion: offers an explanation of the results of the study and should limit itself to the subject matter of the paper. Cite figures consecutively in the text and number them in the order in which they are presented. Figures must be submitted as separate files and not embedded in the word document. CANCER CLASSIFICATION SCHEME The European Journal of Ophthalmology encourages Authors to use the classification scheme proposed by the American Joint Commission on Cancer. Please use these when describing patients with ophthalmic malignancies (see AJCC Cancer Staging Manual, 7th Edition, Springer New Yok) ACKNOWLEDGEMENTS Acknowledge statistical consultation and assistance or writing assistance (when provided by a person different from the author) in an acknowledgement at the end of the article before the references Indicate the name, degree and affiliation of the individual. For all others assisting in

6 the preparation of a manuscript acknowledgements cannot be done, however valuable their service. REFERENCES 1. If you use automated reference numbering software or bibliography software, turn it off before submitting the manuscript. 2. References should follow the text and begin on a separate page. 3. hey must be double-spaced and numbered consecutively in order of appearance in the text, using the automated numbering tool of Word. 4. Identify references in text, tables, and legends in Arabic numerals in parentheses, i.e. (7). 5. If there are 6 or fewer authors, all authors should be listed. If there are more than 6 authors, list the first three and then et al 6. References used within tables should appear as footnotes in the table legend. These references should not be repeated in the main reference list unless they are also cited within the text. 7. List only references pertinent to the manuscript, which you have read and that the reader can retrieve in a literature research. 8. Journals names should be abbreviated according to Index Medicus/Medline. If there is any doubt about abbreviation of a journal name, it should be spelled out completely. 9. All references must be verified by the Author(s) against the original documents. 10. Personal communications, unpublished data, abstracts, oral or poster presentations should be limited and incorporated in parentheses within the text without a reference number. 11. Any references to studies (including books or articles) that have been accepted for publication, but not yet published, should indicate where they will be published and have the term in press in the reference in place of volume and page numbers. These must be updated prior to publication, if possible. 12. Delete digits when in the same range: or (NOT ; ) 13. Do not add a discussion or comment to a reference. If applicable indicate it as Eur J Ophthalmol. 2007;17:534-7, Comment in: Eur J Ophthalmol. 2009;19:327; author reply Suffixes such as Jr, Sr, and III follow authors initials Reference formatting examples: Standard journal article: (List all Authors when six or less; when seven or more, list only first three and add et al.) Gass JD, Harbin TS Jr, Del Piero EJ. Exudative stellate neuroretinopathy and Coats Syndrome in patients with progressive hemifacial atrophy. Eur J Ophthalmol. 1991;1:2-10. Book: Harrington DO, Drake MV. The visual field. Text and atlas of clinical perimetry, 6th ed. St Louis: CV Mosby, 1990; 156. FIGURE LEGENDS Starting on a new page, type legends for figures double-spaced, with Arabic numerals corresponding to the figures. All figures must have a legend. When symbols, arrows, numbers, or letters are used to identify parts of the figures, identify and explain each one clearly in the legend. Any figure that has been published elsewhere should have an acknowledgment to the original source; a copy of the release to publish the figure, signed by the copyright holder, must also be submitted. TABLES As a general rule, tables should not unnecessarily offer duplicate information given in the text. Starting on a new page, type each table on a separate sheet, using double spacing. Tables should be created in a Word document using the table tools.do not format tables as columns or tabs and do not submit tables as figures. Tables should be numbered consecutively in Roman numerals by order of citation in the text. Each table must include title, appropriate column he-

7 ads and explanatory legends, including definitions of any abbreviation used. References used within tables should appear as footnotes in the table legend. These references should not be repeated in the main reference list unless they are also cited within the text. SUMMARY STATEMENT On a separate file please supply a summary statement (90/100 words) describing the purpose, the methodological outline and the main outcomes of your submission. The objective of this is to provide the reader with a brief, quick and focused summary of your work in the perspective of other data. This is different from a version of the Abstract and is not a cover letter. (An example: This pilot study, the first of its type, was conducted to determine the features of five different types of metals on computed tomographic (CT) scan. Pre-measured spherical pieces of iron, copper, lead, aluminum and silver were inserted into animal eyes. All five metal types measured on CT were larger than actual size. Iron was enlarged by a factor of 2.29; silver, 1.77; copper, 1.26; and aluminum, Features including central core, ring density and artifacts varied for each type of metal, giving each one a characteristic appearance.) FIGURES AND ILLUSTRATIONS Cite figures consecutively in the text, and number them in the order in which they are discussed. Figures must be submitted as individual files, choosing figure in the pull down menu in the Attach file step during the submission. Below it there is the Description box; where you should enter the figure number. Do not enter legends here, just the figure number. Please name figure files as fig. 1, fig. 2 etc. Always ensure that the file extension is present to ensure quick and easy format identification. Clinical photographs (including those generated electronically from machines such as MRIs, fluorescein angiography, visual fields, etc.) must be masked to prevent identification of the patient. Clinical photographs that permit identification of an individual (those exposing anything more than just the eyes) must be accompanied by a signed statement by the patient or guardian granting permission for publication of the pictures for educational purposes. Do not embed figures in the Word document. If figures are not submitted in a high enough resolution for publishing, they will be returned to the author. Digital art should be created/scanned, saved and submitted as either a TIFF (tagged image file format) or an EPS (encapsulated postscript) file. Do not submit figures as PPT files (Powerpoint files). Electronic photographs and scanned images must have a resolution of at least 300 dpi. Line art must have a resolution of at least 1200 dpi. Any figure containing text should be saved only as TIFF file. Color images must be created/scanned and saved and submitted as CMYK files. The physical dimensions of any artwork must fit within the dimensions of the pages within the Journal. (i.e., width no more than 10 cm) No text should appear on the face of a figure. Lettering, arrows, and other symbols should be large enough to remain legible after reduction to a figure with a base of 10 cm. All symbols or letters that appear on the figures should be defined in the legend. Composites are recommended for figures in more parts (e.g., Fig 1A, 1B, 1C, 1D, 1E), labeled using typed text in a corner of the each image. Composite are encouraged for multipanel figures. Arial font should be used for any lettering or text on a figure. If possible use the same font type and size in all artworks (we recommend Arial 12). The Author should use colour figures only when necessary. If a manuscript has been submitted, reviewed and accepted with colour figures, then it MUST be published with colour figures. The

8 publisher charges authors directly for colour figures included in their manuscript. Colour figure charge is Euro 500,00 for the first page plus Euro 80,00 for each additional page. Authors will receive a colour charge form from the publisher together with the typeset proofs, to be returned completed with the corrected proofs. SUPPLEMENTARY MATERIAL Supplementary material may be submitted for consideration for posting on the internet, together with the initial submission. Appropriate content may include expanded data sets and spreadsheets, additional digitized figures and illustrations, videos, or expanded techniques and methods sections. Supplementary material must be listed on the title page of your submission and should be cited in the manuscript text in parentheses, in a similar way as when citing a figure or a table. Provide a legend for each Supplementary material submitted. All material submitted as supplementary, will be available to reviewers. Accepted file formats: MP4, MPEG (.mpg), Quicktime (.mov), or Microsoft (.avi) Maximum size: 10 Mb Patients should not be identifiable, or their pictures must be accompanied by written permission to use the video. If the software used for the creation of your video(s)/animation(s) cannot deliver one of the above formats, then please save them in one of the accepted formats. It is the author s responsibility to supply video files in the correct format. The journal will not consider video material not submitted according to specifications. GUIDELINES FOR LETTERS TO EDITOR The European Journal of Ophthalmology is open to correspondence only related to articles published in the journal in the last 8 weeks (date of online publication). Generally, letters to the Editor offer additional information, corrections or opinions on published articles. If accepted, Letters to the Editor will be published online only together with the reply from the author whose work is being commented. Letters to Editor should be typed double-spaced and be no more than 3 pages in length including no more than 5 references. All Letters to Editor must contain a Title Page as indicated for Original Manuscripts. The letters should start with Dear Editor and the article being commented on should be referenced in the first paragraph of the letter and be ref. n. 1. The Letter should end with the name, degree and location for each author. (for example: Rosario Brancato, MD, Milan - Italy). Copyright Transfer forms must be scanned and included with the submission after original signatures are obtained by all authors. Please refer to Transfer of Copyright above. Process: upon receipt, the Letter will be reviewed by the Editor in Chief, who may invite the Corresponding Author of the article being commented on to respond to it. If the invitation is accepted both letter and reply will be edited, reference checked and published together. If the invitation to reply is declined, the Editor in Chief may decide to publish the letter by itself. If you are the Corresponding Author of the article cited in a Letter to Editor and receive an invitation to comment on it, you must log in to the system, accept the invitation immediately and then upload and submit your reply within 20 days to the Editorial Office. The response must cite the title of the letter, e.g. Response to (Title of Letter).

9 REVIEW PROCESS Manuscripts are assigned a unique number and all correspondence and enquiries regarding the manuscript must report this ID number. Usually two and sometimes more reviewers will review a manuscript. The Journal does not reveal the identity of its reviewers but does send pertinent comments back to the corresponding author. It is the Corresponding Author s responsibility to check periodically on the status of their manuscript. A decision letter will be sent by to the Corresponding author with detailed instructions if a revised version is required. Re-review may be required after revision. A point-by-point response is required to the reviewers comments (full instructions will be provided in the decision letter). SUBMISSION OF A REVISED MANUSCRIPT If it is determined through the review process that your manuscript requires revision, you will receive an containing all comments from the reviewers and instructions to submit your revision. The revised version must be submitted within 60 days from the date of the decision letter (30 days for case reports). Revisions not received within the allotted time will not be considered. If for any reason you decide not to revise your manuscript please make sure you log in as Author and click on the Decline to revise link, to notify the Editorial Office, Editor and Reviewers. Log in as An Author with your username and password. The manuscript will be in the folder Submissions needing revision. 1) Download all files which need revision by clicking on the Download files button. Do not work on the files stored in your own computer, but on the version available in the system, as sometimes minor stylistic changes are made. 2) Make changes to the text (remember to mark them in colour), figures, etc. according to the reviewers comments. 3) Using the Reference Checking tool supplied online correct all references which are not validated; 4) Prepare and save on your computer a point-by-point Response to Reviewers that clearly states how each issue raised by the reviewers has been covered and where it can be found (each reviewer s comment followed by the relative author reply, the page and line numbers where the changes have been made, using as a guide the pdf created by the system). All changes must be marked in colour in the manuscript file. You will not need to upload this file, but to copy and paste it in the space provided during the submission process of your revised submission. When all files are revised as needed, log in again as an Author go to the folder Submissions needing revision and click on Submit revision. 1) Submit the manuscript file and figure files revised according to the Reviewers comments, 2) Submit a point-by-point Response to Reviewers Refer to the Author Tutorial supplied online which offers detailed instructions for revised submissions. PUBLICATION PROCESS The Editor-in-Chief accepts the manuscript with the understanding that the Authors cooperate in a timely manner with the production process, including any response to future correspondence from the EJO or its readers. If the submission is accepted, it will be edited to conform with Editorial Board policy in accordance with the Uniform requirements for manuscripts submitted to biomedical journals.

10 The corresponding author will receive typeset page proofs online. Each corresponding author is expected to proofread all pages carefully and answer all queries posed by the copy editor. The Journal reserves final editorial approval for style, format, and grammar. PAGE PROOFS The Corresponding author will receive an of notification, complete with detailed instructions, that proofs are ready for approval in their Author s folder in Editorial Manager for EJO. Proofs must be reviewed carefully by more than one person and returned within 48 hours only through Editorial Manager for EJO to avoid any delay. It is the author s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content and Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. AUTHORSHIP CHANGES including adding or removing Authors CAN NOT BE SUBMITTED WITH PROOF CHANGES. The publisher is not authorized to make such changes and it will delay the publication of your manuscript (see Authorship criteria) OFFPRINTS Authors will receive an offprint order form and a price list with the page proofs. Reprint requests should be returned with the corrected proofs. Reprints ordered post publication are subject to a surcharge of 40% to cover for additional production costs. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. For enquiries contact the Technical Editor of the Journal ([email protected] ). EARLY ONLINE RELEASE After the proofs have been approved by the author, manuscripts are available online in the section Article In Press of the Journal The only difference with the final published version is that the page numbers have not yet been assigned and when an article is assigned to an issue it will be removed from the section. This early online release is not a draft version since it is produced after all editorial and author corrections are made but no routine editing will occur once the article is online. The publication online in the section Articles in Press is not meant to be a last editing opportunity for authors: however, if a major, critical error is found we may be able to make corrections prior to publication or an erratum will be published in a future issue. It is the corresponding author s responsibility that all editing be done when returning the corrected proofs to the publisher and that the publisher is notified immediately if the authors do not wish to have the article included in this section. All notifications regarding proof approvals, proof corrections or requests that an article not be released in press prior to publication must be made only through Editorial Manager for EJO upon submission of the proof correction.